Table 3.
Perirenal | Epididymal | ||||
---|---|---|---|---|---|
Groups | Cell cross-sectional area (µm2) | Cell number (×104) | Cell cross-sectional area (μm2) | Cell number (×104) | |
NOR | 16,434 ± 2033 b | 7.52 ± 0.88 a | 14,555 ± 2766 a | 7.40 ± 0.95 a | |
HF | 23,453 ± 3397 c | 14.85 ± 2.63 d | 22,400 ± 3097 b | 13.07 ± 1.33 c | |
UPW-R-1X | 19,283 ± 3455 b | 12.87±1.57 cd | 19,465 ± 2122 b | 10.45± 0.89 b | |
DOW-R-1X | 16,023 ± 2745 a | 11.45±0.98 c | 15,390 ±1983 a | 8.44± 1.45 ab | |
DOW-R-2X | 14,005 ± 2409 a | 10.44±1.08 b | 14,186 ± 2309 a | 7.64± 1.04 a | |
MS | 15,093 ± 3011 a | 9.50 ± 1.57 ab | 15,123 ± 2793 a | 7.28 ± 1.37 a | |
AK | 14,302 ± 2320 a | 9.90 ± 1.56 ab | 14,907 ± 2123 a | 7.44± 1.58 a |
NOR, normal diet (3.34 kcal/g); HF, high-fat diet (4.17 kcal/g); UPW-R-1X, UPW-RMD powder (1×, 27.81 mg/day 100 g bw) and high-fat diet; DOW-R-1X, DOW-RMD powder (1×, 27.81 mg/day 100 g bw) and high-fat diet; DOW-R-2X, DOW-RMD powder (2×, 55.62 mg/day 100 g bw) and high-fat diet; and high-fat diet; MS, monascin powder (2×, 0.152 mg/day 100 g bw) and high-fat diet; AK, ankaflavin powder (2×, 0.162 mg/day 100 g bw) and high-fat diet. Data are presented as means ± SD (n = 8). Mean values within each column with different superscripts are significant difference (p < 0.05).